Literature DB >> 26102026

A phosphomimetic mutant TDP-43 (S409/410E) induces Drosha instability and cytotoxicity in Neuro 2A cells.

Ki Yoon Kim1, Hee-Woo Lee2, Yu-Mi Shim2, Inhee Mook-Jung3, Gye Sun Jeon4, Jung-Joon Sung5.   

Abstract

Two DNA/RNA binding proteins, TDP-43 and FUS/TLSU, are involved in RNA processing, and their aberrant mutations induce inherited amyotrophic lateral sclerosis and frontotemporal lobar degeneration with ubiquitinated inclusions. Wild type TDP-43 and FUS (wtTDP-43 and wtFUS) are mainly localized in the nucleus and biochemically interact with the microRNA processing enzyme Drosha. In this study, we investigated Drosha stability in Neuro 2A cells by gain and loss of function studies of wtTDP-43 and wtFUS and cycloheximide mediated protein degradation assay. We also generated three different phosphomimetic mutants of TDP-43 (S379E, S403/404E and S409/410E) by using a site-directed mutagenesis method and examined Drosha stability to elucidate a correlation between the phosphorylated TDP-43 mutants and Drosha stability. Overexpression of wtTDP-43 and/or wtFUS increased Drosha stability in Neuro 2A cells and double knockdown of wtTDP-43 and wtFUS reduced its stability. However, knockdown of wtTDP-43 or wtFUS did not affect Drosha stability in Neuro 2A cells. Interestingly, a phosphomimetic mutant TDP-43 (S409/410E) significantly reduced Drosha stability via prevention of protein-protein interactions between wtFUS and Drosha, and induced cytotoxicity in Neuro 2A cells. Our findings suggest that TDP-43 and FUS controls Drosha stability in Neuro 2A cells and that a phosphomimetic mutant TDP-43 (S409/410E) which is associated with Drosha instability can induce neuronal toxicity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drosha; FUS; Phosphomimetic mutant TDP-43 (S409/410E); TDP-43

Mesh:

Substances:

Year:  2015        PMID: 26102026     DOI: 10.1016/j.bbrc.2015.06.125

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance.

Authors:  Manuela Neumann; Edward B Lee; Ian R Mackenzie
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Frontotemporal Lobar Degeneration and MicroRNAs.

Authors:  Paola Piscopo; Diego Albani; Anna E Castellano; Gianluigi Forloni; Annamaria Confaloni
Journal:  Front Aging Neurosci       Date:  2016-02-09       Impact factor: 5.750

3.  Downregulated miR-18b-5p triggers apoptosis by inhibition of calcium signaling and neuronal cell differentiation in transgenic SOD1 (G93A) mice and SOD1 (G17S and G86S) ALS patients.

Authors:  Ki Yoon Kim; Yu Ri Kim; Kyung Won Choi; Mijung Lee; Somyung Lee; Wooseok Im; Je-Young Shin; Jin Young Kim; Yoon Ho Hong; Manho Kim; Jong-Il Kim; Jung-Joon Sung
Journal:  Transl Neurodegener       Date:  2020-07-01       Impact factor: 8.014

4.  FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade.

Authors:  Pierre De Rossi; Amanda J Lewis; Johanna Furrer; Laura De Vos; Tomas Demeter; Aurélie Zbinden; Weijia Zhong; Vera I Wiersma; Carlo Scialo; Julien Weber; Zhongning Guo; Stefano Scaramuzza; Marta Di Fabrizio; Carolin Böing; Daniel Castaño-Díez; Ashraf Al-Amoudi; Manuela Pérez-Berlanga; Tammaryn Lashley; Henning Stahlberg; Magdalini Polymenidou
Journal:  EMBO Rep       Date:  2021-11-22       Impact factor: 8.807

5.  LRRK2 Contributes to Secondary Brain Injury Through a p38/Drosha Signaling Pathway After Traumatic Brain Injury in Rats.

Authors:  Qin Rui; Haibo Ni; Fan Gao; Baoqi Dang; Di Li; Rong Gao; Gang Chen
Journal:  Front Cell Neurosci       Date:  2018-03-01       Impact factor: 5.505

6.  Glucose 6-phosphate dehydrogenase 6-phosphogluconolactonase: characterization of the Plasmodium vivax enzyme and inhibitor studies.

Authors:  Kristina Haeussler; Isabell Berneburg; Esther Jortzik; Julia Hahn; Mahsa Rahbari; Norma Schulz; Janina Preuss; Viktor A Zapol'skii; Lars Bode; Anthony B Pinkerton; Dieter E Kaufmann; Stefan Rahlfs; Katja Becker
Journal:  Malar J       Date:  2019-01-25       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.